pelubiprofen: Clinical Trials

8 trials of pelubiprofen, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 2 unknown, 1 recruiting. 5 Phase 3, 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 35Completed 3, Unknown 2
Phase 13Completed 2, Recruiting 1

Follow pelubiprofen: new trials by email Literature Review of pelubiprofen trials Research Report on pelubiprofen

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparison of DW-1021 and Separate Doses of Pelubi CR and Zytram CR Under Fasting Conditions
DW-1021, Pelubi CR + Zytram CR - Healthy Volunteer
Phase 1RecruitingHaiphong University of Medicine and Pharmacy142025-09-202025-08-28
Phase 3 Clinical Trial to Evaluate of the Efficacy and Safety of DW9801 in Patients With Primary Dysmenorrhea
Pelubiprofen 45mg, Placebo - Primary Dysmenorrhea
Phase 3UnknownDaewon Pharmaceutical Co., Ltd.1202020-09-302020-09-09
Clinical Trial to Evaluate the Efficacy and Safety of 'Pelubiprofen Controlled Released Tab.' in Acute Traumatic Injury
pelubiprofen 45mg, pelubiprofen placebo - Acute Traumatic Injury
Phase 3UnknownDaewon Pharmaceutical Co., Ltd.942019-02-252019-03-19
Phase 3 Study of DW-330SR2 and Pelubiprofen in Chronic Back Pain Patients
DW-330SR2, Pelubiprofen - Chronic Back Pain
Phase 3CompletedDaewon Pharmaceutical Co., Ltd.1662014-04-012016-10-10
Phase 3 Study of Pelubiprofen & Loxoprofen in Patients With Upper Respiratory Tract Infection
Pelubiprofen, Loxoprofen - Acute Upper Respiratory Infection, Fever
Phase 3CompletedDaewon Pharmaceutical Co., Ltd.1832013-01-012016-10-10
Phase 1 Study to Compare the Pharmacokinetic Characteristics and Food Effect of Pelubiprofen (30mg) Tablet IR TID and Pelubiprofen SR (as a Pelubiprofen 90 mg) Tablet QD in Healthy Subjects
pelubiprofen (30mg) tablet IR, pelubiprofen SR (as a pelubiprofen 90 mg) tablet - Healthy
Phase 1CompletedDaewon Pharmaceutical Co., Ltd.2012-03-012013-01-28
Phase 3 Study of Pelubiprofen Tab. & Celebrex Cap. in Rheumatoid Arthritis Patients
Pelubiprofen 30 mg, Celebrex 200 mg - Pelubiprofen, Celebrex
Phase 3CompletedDaewon Pharmaceutical Co., Ltd.1202010-10-012013-08-09
Phase 1 Study to Compare the Pharmacokinetic Characteristics and Food Effect of Pelubiprofen (30mg) Tablet IR and Pelubiprofen SR (as a Pelubiprofen 45 mg) Tablet in Healthy Subjects
Pelubiprofen IR (Pelubiprofen 30mg) TID, Pelubiprofen SR (Pelubiprofen 45 mg) BID - Healthy Males
Phase 1CompletedDaewon Pharmaceutical Co., Ltd.2014-01-14

Conditions studied

Arthritis, Rheumatoid (1)  ·  Fever (1)

Sponsors

Daewon Pharmaceutical Co., Ltd. (7)  ·  Haiphong University of Medicine and Pharmacy (1)

Countries

South Korea (2)  ·  Vietnam (1)

Results publications

PMID 25403311, PMID 40094866, PMID 41821212